Celyad Oncology SA
XBRU:CYAD

Watchlist Manager
Celyad Oncology SA Logo
Celyad Oncology SA
XBRU:CYAD
Watchlist
Price: 0.65 EUR -2.99% Market Closed
Market Cap: 14.7m EUR
Have any thoughts about
Celyad Oncology SA?
Write Note

Relative Value

The Relative Value of one CYAD stock under the Base Case scenario is 0.03 EUR. Compared to the current market price of 0.65 EUR, Celyad Oncology SA is Overvalued by 96%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CYAD Relative Value
Base Case
0.03 EUR
Overvaluation 96%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
58
vs Industry
14
Median 3Y
0
Median 5Y
86.4
Industry
7.7
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-1.9
Industry
22.7
vs History
vs Industry
Median 3Y
-0.7
Median 5Y
-1.7
Industry
21.6
vs History
vs Industry
Median 3Y
-0.7
Median 5Y
-1.6
Industry
25.2
vs History
80
vs Industry
46
Median 3Y
1.4
Median 5Y
3.4
Industry
2.5
vs History
60
vs Industry
19
Median 3Y
0
Median 5Y
17.9
Industry
7.7
vs History
46
vs Industry
7
Median 3Y
0
Median 5Y
-6.3
Industry
9
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-1.6
Industry
4.2
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-1.5
Industry
4.1
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.9
Industry
5.7
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.9
Industry
3.6
vs History
84
vs Industry
64
Median 3Y
0.5
Median 5Y
1.7
Industry
4.6

Multiples Across Competitors

CYAD Competitors Multiples
Celyad Oncology SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
BE
Celyad Oncology SA
XBRU:CYAD
14.7m EUR 204 -1.9 -1.2 -1.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 797 580.3 -179 646.3 -218 147.8 -215 658.5
US
Abbvie Inc
NYSE:ABBV
320.1B USD 5.8 63 15.6 24.1
US
Amgen Inc
NASDAQ:AMGN
150.5B USD 4.6 35.6 16.8 31.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.4B USD 11.3 -250.9 25 26.3
US
Gilead Sciences Inc
NASDAQ:GILD
113.8B USD 4 903.4 10 10
US
Epizyme Inc
F:EPE
94.1B EUR 1 863.9 -475.6 -517.9 -504.1
AU
CSL Ltd
ASX:CSL
135.4B AUD 5.9 33.1 20.5 25.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.9B USD 6 17.8 16.3 18.1
US
Seagen Inc
F:SGT
39.3B EUR 18 -55.1 -59.2 -53.4
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.6 -130.7 -105.2 -76.6
P/E Multiple
Earnings Growth
BE
Celyad Oncology SA
XBRU:CYAD
Average P/E: 210.6
Negative Multiple: -1.9
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -179 646.3 N/A
US
Abbvie Inc
NYSE:ABBV
63
412%
US
Amgen Inc
NASDAQ:AMGN
35.6
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -250.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
903.4
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -475.6 N/A
AU
CSL Ltd
ASX:CSL
33.1
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.1 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130.7 N/A
EV/EBITDA Multiple
EBITDA Growth
BE
Celyad Oncology SA
XBRU:CYAD
Average EV/EBITDA: 17.4
Negative Multiple: -1.2
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 147.8 N/A
US
Abbvie Inc
NYSE:ABBV
15.6
29%
US
Amgen Inc
NASDAQ:AMGN
16.8
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25
43%
US
Gilead Sciences Inc
NASDAQ:GILD
10
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -517.9 N/A
AU
CSL Ltd
ASX:CSL
20.5
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.3
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.2 N/A
EV/EBIT Multiple
EBIT Growth
BE
Celyad Oncology SA
XBRU:CYAD
Average EV/EBIT: 22.6
Negative Multiple: -1.1
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -215 658.5 N/A
US
Abbvie Inc
NYSE:ABBV
24.1
88%
US
Amgen Inc
NASDAQ:AMGN
31.8
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.3
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -504.1 N/A
AU
CSL Ltd
ASX:CSL
25.5
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.1
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.6 N/A

See Also

Discover More
Back to Top